The Effects of Cocaine in Buprenorphine-Maintained Outpatient Volunteers: Results from Clinical Experience and Laboratory Challenges

References

• Rouse BA. Trends in cocaine use in the general population. The Epidemiology of Cocaine Use and Abuse, S Schober, C. Schade. U.S. Government Printing Office, Washington, DC 1991; 5–18, National Institute on Drug Abuse Research Monograph 110
   Google Scholar
• National Institute on Drug Abuse National Household Survey on Drug Abuse: Main Findings. DHHS, Rockville, MD 1988; 1990, Publication No. 90-1682
   Google Scholar
• Rinfret M. Cocaine price purity, and trafficking trends. The Epidemiology of Cocaine Use and Abuse, S Schober, C. Schade. U.S. Government Printing Office, Washington, DC 1991; 297–304, National Institute on Drug Abuse Research Monograph 110.
   Google Scholar
• Rawson R A, Obert J L, McCann M J, et al. Cocaine abuse treatment: a review of current strategies. J Subst Abuse 1991; 3: 457–491
   PubMedGoogle Scholar
• Des Jariais D C, Friedman S R, Novick D M, et al. HIV-1 infection among intravenous drug users in Manhattan New York City from 1977 through 1987. JAMA 1989; 261: 1008–1012
   Google Scholar
• Hahn R A, Onorato I M, Jones S, et al. Prevalence of HIV infection among intravenous drug users in the United States. JAMA 1989; 261: 2677–2684
   PubMed Web of Science ®Google Scholar
• Schoenbaum E E, Hartel D, Selwyn P A, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989; 321: 874–879
   PubMed Web of Science ®Google Scholar
• Preston K L, Sullivan J T, Strain E C, et al. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther 1992; 262: 279–291
   Google Scholar
• Hubner C B, Koob GF. Bromocriptine produces decreases in cocaine self-administration in the rat. Neuropsychopharmacology 1990; 3: 101–108
   Google Scholar
• Sannerud C A, Griffiths RR. Amantadine: evaluation of reinforcing properties and effect on cocaine self-injection in baboons. Drug Alcohol Depend 1988; 21: 195–202
   Google Scholar
• Katz J L, Witkin JM. Behavioral effects of cocaine alone and in combination with selective dopamine antagonists in the squirrel monkey. Psychopharma-cology 1991; 103: 33–40
   Google Scholar
• Sherer M A, Kumor K M, Jaffe JH. Effects of intravenous cocaine are partially attenuated by haloperi-dol. Psychiatry Res 1989; 27: 117–125
   PubMed Web of Science ®Google Scholar
• Carroll M E, Lac S T, Asencio M, et al. Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Psychopharmacology 1990; 100: 293–300
   PubMedGoogle Scholar
• Richardson N R, Roberts D CS. Fluoxetine pretreat-ment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci 1991; 49: 833–840
   PubMed Web of Science ®Google Scholar
• Carroll M E, Lac S T, Asencio M, et al. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 1990; 35: 237–244
   PubMed Web of Science ®Google Scholar
• Muntaner C, Kumor K M, Nagoshi C, et al. Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans. Psychopharmacology 1991; 105: 37–41
   PubMed Web of Science ®Google Scholar
• Pani L, Kuzmin A, Diana M, et al. Calcium receptor antagonists modify cocaine effects in the central nervous system differently. Eur J Pharmacol 1990; 190: 217–221
   Google Scholar
• Fischman M W, Foltin R W, Nestadt G, et al. Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 1990; 253: 760–770
   PubMed Web of Science ®Google Scholar
• Mello N K, Lukas S E, Bree M P, et al. Desipramine effects on cocaine self-administration by rhesus monkeys. Drug Alcohol Depend 1990; 26: 103–116
   PubMedGoogle Scholar
• Gawin F H, Kleber H D, Byck R, et al. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46: 117–121
   PubMed Web of Science ®Google Scholar
• Rowbotham M C, Jones R T, Benowitz N L, et al. Trazodone-oral cocaine interactions. Arch Gen Psychiatry 1984; 41: 895–899
   PubMed Web of Science ®Google Scholar
• Scott M E, Mullaly RW. Lithium therapy for cocaine-induced'psychosis: a clinical perspective. South MedJ 1981; 74: 1475–1477
   Google Scholar
• Cronson A J, Flemenbaum A. Antagonism of cocaine highs by lithium. Am J Psychiatry 1978; 135: 856–857
   PubMed Web of Science ®Google Scholar
• Halikas J A, Crosby R D, Carlson G A, et al. Cocaine reduction in unmotivated crack users using car-bamazepine versus placebo in a short-term, double-blind crossover design. Clin Pharmacol Ther 1991; 50: 81–95
   PubMed Web of Science ®Google Scholar
• Hatsukami D, Keenan R, Halikas J, et al. Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users. Psychopharmacology 1991; 104: 120–124
   Google Scholar
• Carroll M E, Lac S T, Asencio M, et al. Effects of carbamazepine on self-administration of intravenously delivered cocaine in rats. Pharmacol Biochem Behav 1990; 37: 551–556
   Google Scholar
• Mello N K, Mendelson JH. Buprenorphine suppresses heroin use by heroin addicts. Science 1980; 207: 657–659
   PubMed Web of Science ®Google Scholar
• Johnson R E, Jaffe J H, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992; 267: 2750–2755
   PubMed Web of Science ®Google Scholar
• Bickel W K, Stitzer M L, Bigelow G E, et al. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther 1988; 43: 72–78
   PubMed Web of Science ®Google Scholar
• Strain E C, Stitzer M L, Liebson I A, et al. A comparison of buprenorphine to methadone in the treatment of opioid dependence. Am J Psychiatry 1994, in press
   Google Scholar
• Mello N K, Mendelson J H, Bree M P, et al. Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science 1989; 245: 859–862
   PubMedGoogle Scholar
• Kosten T R, Kleber H D, Morgan C. Treatment of cocaine abuse with buprenorphine. Biol Psychiatry 1989; 26: 637–639
   PubMed Web of Science ®Google Scholar
• Kosten T R, Kleber H D, Morgan C. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 1989; 44: 887–892
   PubMed Web of Science ®Google Scholar
• Mello N K, Lukas S E, Kamien J B, et al. The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol ExpTher 1992; 260: 1185–1193
   Google Scholar
• Mello N K, Kamien J B, Lukas S E, et al. Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 1993; 264: 530–541
   Google Scholar
• Brown E E, Finlay J M, Wong J TF, et al. Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 1991; 256: 119–126
   Google Scholar
• Crowley T J, Williams E A, Mikulich S K, et al. Buprenorphine and cocaine effects on social behavior of monkeys. Drug Alcohol Depend 1993; 31: 235–245
   Google Scholar
• Dykstra L A, Doty P, Johnson A B, et al. Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine, and naltrexone. Drug Alcohol Depend 1992; 30: 227–234
   Google Scholar
• Martin W R, Sloan J W, Sapiro J D, et al. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1971; 12: 245–258
   PubMed Web of Science ®Google Scholar
• Kolb L, Himmelsbach CK. Clinical studies of drug addiction, HI: a critical review of the withdrawal treatments with method of evaluating abstinence syndromes. Am J Psychiatry 1938; 94: 759–799
   Google Scholar
• Foreman N, Barraclough S, Moore C, et al. High doses of caffeine impair performance of a numerical version of the Stroop task in men. Pharmacol Biochem Behav 1989; 32: 399–403
   PubMed Web of Science ®Google Scholar
• McLeod D, Griffiths R R, Bigelow G E, et al. An automated version of the Digit Symbol Substitution Test (DSST). Behavior Research Methods and Instrumentation 1982; 14: 463–466
   Google Scholar
• Beck A T, Ward C H, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 53–63
   Web of Science ®Google Scholar
• Strain E C, Stitzer M L, Bigelow GE. Early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis 1991; 179: 215–221
   PubMed Web of Science ®Google Scholar
• Strain E C, Stitzer M L, Liebson I A, et al. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med 1993; 119: 23–27
   PubMed Web of Science ®Google Scholar